Evidence map›Paper›PMID 35642634›Full record

ArticleThe Journal of clinical investigation2022

Lymphocyte crosstalk is required for monocyte-intrinsic trained immunity to Plasmodium falciparum.

Juliet N Crabtree, Daniel R Caffrey, Leandro de Souza Silva, Evelyn A Kurt-Jones, Katherine Dobbs, Arlene Dent, Katherine A Fitzgerald, Douglas T Golenbock

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 28 citations in OpenAlex.

  1. Stress Hyperglycemia Drives CD4Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. C1q reprograms innate immune memory.Frontiers in immunology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Heat-killediScience · 2024
    Article
  19. Trained Innate Immunity in Animal Models of Cardiovascular Diseases.International journal of molecular sciences · 2024
    Review
  20. Potent induction of trained immunity byFrontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Juliet N CrabtreeProgram in Innate Immunity and.
Daniel R CaffreyProgram in Innate Immunity and.
Leandro de Souza SilvaProgram in Innate Immunity and.
Evelyn A Kurt-JonesProgram in Innate Immunity and.
Katherine DobbsCase Western University, Cleveland, Ohio, USA.
Arlene DentCase Western University, Cleveland, Ohio, USA.
Katherine A FitzgeraldProgram in Innate Immunity and.
Douglas T GolenbockProgram in Innate Immunity and.
University of Massachusetts Chan Medical School · USCase Western Reserve University · US

Funding

Innate Immune Activation in MalariaR01AI079293 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., GOLENBOCK, DOUGLAS T · 2009 to 2024
$10.9M
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in KenR01AI095192 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2011 to 2015
$3.2M
Translational Cancer Biology Training ProgramT32CA130807 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MERCURIO, ARTHUR M · 2008 to 2018
$2.7M
Asymptomatic Malaria Gametocyte levels in Kenya: An observational surveyR01AI116709 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI GRIMBERG, BRIAN T. · 2015 to 2019
$1.9M
Epigenetic Reprogramming of Monocyte Functions during Acute Uncomplicated Malaria in Kenyan ChildrenK23AI132644 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI DOBBS, KATHERINE ROSE · 2018 to 2022
$948k
NCI NIH HHS T32 CA130807NIAID NIH HHS K23 AI132644NIAID NIH HHS R01 AI079293NIAID NIH HHS R01 AI095192NIAID NIH HHS R01 AI116709
6 · The paper itself

Abstract

Plasmodium falciparum (P. falciparum) induces trained innate immune responses in vitro, where initial stimulation of adherent PBMCs with P. falciparum-infected RBCs (iRBCs) results in hyperresponsiveness to subsequent ligation of TLR2. This response correlates with the presence of T and B lymphocytes in adherent PBMCs, suggesting that innate immune training is partially due to adaptive immunity. We found that T cell-depleted PBMCs and purified monocytes alone did not elicit hyperproduction of IL-6 and TNF-α under training conditions. Analysis of P. falciparum-trained PBMCs showed that DCs did not develop under control conditions, and IL-6 and TNF-α were primarily produced by monocytes and DCs. Transwell experiments isolating purified monocytes from either PBMCs or purified CD4+ T cells, but allowing diffusion of secreted proteins, enabled monocytes trained with iRBCs to hyperproduce IL-6 and TNF-α after TLR restimulation. Purified monocytes stimulated with IFN-γ hyperproduced IL-6 and TNF-α, whereas blockade of IFN-γ in P. falciparum-trained PBMCs inhibited trained responses. Assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-Seq) on monocytes from patients with malaria showed persistently open chromatin at genes that appeared to be trained in vitro. Together, these findings indicate that the trained immune response of monocytes to P. falciparum is not completely cell intrinsic but depends on soluble signals from lymphocytes.

Indexed as

LymphocytesMalaria, FalciparumMonocytesChromatinHumansInterleukin-6Plasmodium falciparumTumor Necrosis Factor-alphaChromatinInterleukin-6Tumor Necrosis Factor-alphaImmunologyInfectious diseaseInnate immunityMalariaT cells

Identifiers

PMID35642634
PMCPMC9151696
OpenAlexW4281998782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.